脑机接口第一股来了，“DeepSeek时刻”还没来

Core Viewpoint - The brain-computer interface (BCI) sector is gaining significant attention and investment, with major developments from companies like Neuralink and Qiangnao Technology, indicating a potential shift towards commercialization and broader application in various fields [6][12]. Group 1: Industry Developments - Neuralink plans to begin large-scale production by 2026, showcasing the growing momentum in the BCI field [6]. - Qiangnao Technology has completed a financing round of 2 billion yuan and has submitted an IPO application to the Hong Kong Stock Exchange [6]. - The BCI market is projected to reach a size of $400 billion in the U.S. medical market by 2045, with the overall market potentially exceeding $1 trillion [13]. Group 2: Technological Advancements - BCI technology has evolved from a theoretical concept to practical applications, with significant breakthroughs in invasive techniques, such as reducing the time to implant a single electrode from 17 seconds to 1.5 seconds [9][11]. - Non-invasive BCI technologies are emerging, allowing for applications in cognitive enhancement and entertainment, expanding the commercial potential beyond medical uses [11]. Group 3: Challenges to Commercialization - The BCI sector faces several challenges, including the need for technological maturity in signal acquisition and decoding algorithms, as current methods are limited in their ability to capture complex neural signals [16][17]. - High costs associated with BCI devices and procedures, ranging from 150,000 to 350,000 yuan for implantation, hinder widespread adoption [18]. - Privacy concerns regarding the data collected from BCIs necessitate the establishment of legal and ethical frameworks to protect sensitive information [19][20].